Skip to content

5-Amino-1MQ

5-Amino-1MQ, unlabeled white capsules in an amber prescription bottle

5-Amino-1MQ is an investigational research compound, dispensed here as a 50mg capsule, on its own or paired with NMN. It is not an FDA-approved product and human data is limited. It is prescribed only after a licensed provider reviews your history and explains what is and is not known.

Capsule at 50mg, 60 or 90 per supply
Dispensed alone or paired with NMN
Prescribed after a provider review
Choose a 5-Amino-1MQ supply

Pharmacy shipping: $20 added once per medication order.

Start now
Prescription required · Provider review included

About this treatment

Take a closer look at cellular metabolism.

5-Amino-1MQ is being researched for its effects on an enzyme involved in metabolism. IAM offers a compounded capsule, with a provider-led discussion of your weight-care goals, health history and the role of this investigational compound.

Metabolism at the enzyme level

5-Amino-1MQ is a small molecule that inhibits nicotinamide N-methyltransferase, usually shortened to NNMT. This enzyme processes nicotinamide, a form of vitamin B3 involved in the body's NAD metabolism. Scientists are investigating how changing NNMT activity affects the way tissues handle energy.

[1]

A research focus on weight and metabolic health

Research into NNMT inhibition explores fat storage, glucose handling, insulin sensitivity and liver metabolism. These connected areas help explain why 5-Amino-1MQ comes up in discussions of metabolic care. Your consultation can put that research into the context of your own health and treatment goals.

[1][2]

Know what is in your capsule

IAM lists 5-Amino-1MQ as an oral capsule, either on its own or paired with NMN. NMN is a separate NAD precursor. Your provider can explain which preparation is being considered, review your medicines and agree on what to assess during follow-up. The pharmacy label provides the instructions for your prescription.

[1][2]

Research and product information

The cited treatment findings come from laboratory and mouse studies, not human efficacy trials. Benefits and long-term safety of the oral capsule are not established, including preparations paired with NMN.

  1. Neelakantan et al. NNMT inhibition and metabolic research (2018)
  2. Babula et al. 5-Amino-1MQ and obesity-related metabolic pathways (2024)

Sources checked .

Your path to 5-Amino-1MQ

01

Complete the assessment

Share your health history and goals in the patient portal.

02

Provider review

A licensed provider discusses what is and is not known about this compound.

03

Care coordination

Your care team coordinates the prescription after provider approval.

About this treatment

What it is

A small molecule taken by mouth, compounded here as a capsule. It is investigational, human data is limited, and it is not FDA-approved.

Who it's for

Adults whose provider decides an investigational compound is appropriate for them, and who understand how limited the evidence is.

Forms we dispense

Capsule 50mg

Real provider oversight

A licensed provider reviews your history and requests labs when clinically appropriate before prescribing.

Licensed pharmacy coordination

Prescriptions are coordinated with our licensed US pharmacy partner, with dosing supplies included when needed.

Only when appropriate

We do not sell pharmaceuticals online. Every prescription comes after a full provider review.

Frequently asked questions